Synthesis and structure-activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS)

被引:32
作者
Williams, John D. [1 ]
Torhan, Matthew C. [1 ]
Neelagiri, Venugopal R. [1 ]
Brown, Carson [1 ]
Bowlin, Nicholas O. [1 ]
Di, Ming [1 ]
McCarthy, Courtney T. [1 ]
Aiello, Daniel [1 ]
Peet, Norton P. [1 ]
Bowlin, Terry L. [1 ]
Moir, Donald T. [1 ]
机构
[1] Microbiotix Inc, Worcester, MA 01605 USA
基金
美国国家卫生研究院;
关键词
Type III secretion system; Virulence factor; Pseudomonas aeruginosa; Phenoxyacetamide; Mitsunobu reaction; BACTERIAL VIRULENCE; VENTILATED PATIENTS; ANTIBIOTICS; INFECTION; CHALLENGES; RESISTANCE; TARGET; DRUGS;
D O I
10.1016/j.bmc.2015.01.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The increasing prevalence of drug-resistant bacterial infections is driving the discovery and development not only of new antibiotics, but also of inhibitors of virulence factors that are crucial for in vivo pathogenicity. One such virulence factor is the type III secretion system (T3SS), which plays a critical role in the establishment and dissemination of Pseudomonas aeruginosa infections. We have recently described the discovery and characterization of a series of inhibitors of P. aeruginosa T3SS based on a phenoxyacetamide scaffold. To better characterize the factors involved in potent T3SS inhibition, we have conducted a systematic exploration of this structure, revealing several highly responsive structure-activity relationships indicative of interaction with a specific target. Most of the structural features contributing to potency were additive, and combination of those features produced optimized inhibitors with IC50 values <1 mu M. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1027 / 1043
页数:17
相关论文
共 33 条
[1]   Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III Secretion [J].
Aiello, Daniel ;
Williams, John D. ;
Majgier-Baranowska, Helena ;
Patel, Ishan ;
Peet, Norton P. ;
Huang, Jin ;
Lory, Stephen ;
Bowlin, Terry L. ;
Moir, Donald T. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) :1988-1999
[2]   Resistance to antibiotics: Are we in the post-antibiotic era? [J].
Alanis, AJ .
ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (06) :697-705
[3]   Bacterial virulence as a target for antimicrobial chemotherapy [J].
Alksne, LE ;
Projan, SJ .
CURRENT OPINION IN BIOTECHNOLOGY, 2000, 11 (06) :625-636
[4]  
Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685
[5]   Antivirulence drugs to target bacterial secretion systems [J].
Baron, Christian .
CURRENT OPINION IN MICROBIOLOGY, 2010, 13 (01) :100-105
[6]   Mutations in the Pseudomonas aeruginosa Needle Protein Gene pscF Confer Resistance to Phenoxyacetamide Inhibitors of the Type III Secretion System [J].
Bowlin, Nicholas O. ;
Williams, John D. ;
Knoten, Claire A. ;
Torhan, Matthew C. ;
Tashjian, Tommy F. ;
Li, Bing ;
Aiello, Daniel ;
Mecsas, Joan ;
Hauser, Alan R. ;
Peet, Norton P. ;
Bowlin, Terry L. ;
Moir, Donald T. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) :2211-2220
[7]   The dearth of new antibiotic development: why we should be worried and what we can do about it [J].
Charles, PGP ;
Grayson, ML .
MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (10) :549-+
[8]  
Christina Tobin C. T. K., 2013, NAT REV MICROBIOL, V11, P146
[9]   Targeting virulence: a new paradigm for antimicrobial therapy [J].
Clatworthy, Anne E. ;
Pierson, Emily ;
Hung, Deborah T. .
NATURE CHEMICAL BIOLOGY, 2007, 3 (09) :541-548
[10]   Type III secretion systems and disease [J].
Coburn, Bryan ;
Sekirov, Inna ;
Finlay, B. Brett .
CLINICAL MICROBIOLOGY REVIEWS, 2007, 20 (04) :535-+